182 related articles for article (PubMed ID: 10570051)
21. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
[TBL] [Abstract][Full Text] [Related]
22. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
[TBL] [Abstract][Full Text] [Related]
23. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
[TBL] [Abstract][Full Text] [Related]
24. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
25. Interaction between external Na+ and mexiletine on Na+ channel in guinea-pig ventricular myocytes.
Ono M; Sunami A; Hiraoka M
Pflugers Arch; 1995 Nov; 431(1):101-9. PubMed ID: 8584406
[TBL] [Abstract][Full Text] [Related]
26. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
Ragsdale DS; Scheuer T; Catterall WA
Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
[TBL] [Abstract][Full Text] [Related]
27. Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
Pugsley MK; Goldin AL
Eur J Pharmacol; 1998 Jan; 342(1):93-104. PubMed ID: 9544797
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological targeting of long QT mutant sodium channels.
Wang DW; Yazawa K; Makita N; George AL; Bennett PB
J Clin Invest; 1997 Apr; 99(7):1714-20. PubMed ID: 9120016
[TBL] [Abstract][Full Text] [Related]
29. Point mutations at L1280 in Nav1.4 channel D3-S6 modulate binding affinity and stereoselectivity of bupivacaine enantiomers.
Nau C; Wang SY; Wang GK
Mol Pharmacol; 2003 Jun; 63(6):1398-406. PubMed ID: 12761351
[TBL] [Abstract][Full Text] [Related]
30. A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel.
Sunami A; Glaaser IW; Fozzard HA
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2326-31. PubMed ID: 10681444
[TBL] [Abstract][Full Text] [Related]
31. Stable expression and characterization of human PN1 and PN3 sodium channels.
Akiba I; Seki T; Mori M; Iizuka M; Nishimura S; Sasaki S; Imoto K; Barsoumian EL
Recept Channels; 2003; 9(5):291-9. PubMed ID: 14527872
[TBL] [Abstract][Full Text] [Related]
32. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
[TBL] [Abstract][Full Text] [Related]
33. Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle.
Duff HJ; Offord J; West J; Catterall WA
Mol Pharmacol; 1992 Oct; 42(4):570-4. PubMed ID: 1331749
[TBL] [Abstract][Full Text] [Related]
34. Combined class I antiarrhythmic agents have differential effects on tonic and use dependent block of maximum rate of depolarisation of action potentials in guinea pig cardiac muscle.
Nitta J; Sunami A; Furukawa T; Marumo F; Sawanobori T; Hiraoka M
Cardiovasc Res; 1992 May; 26(5):462-9. PubMed ID: 1332827
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
36. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels.
Liu G; Yarov-Yarovoy V; Nobbs M; Clare JJ; Scheuer T; Catterall WA
Neuropharmacology; 2003 Mar; 44(3):413-22. PubMed ID: 12604088
[TBL] [Abstract][Full Text] [Related]
37. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
38. A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel.
Li HL; Galue A; Meadows L; Ragsdale DS
Mol Pharmacol; 1999 Jan; 55(1):134-41. PubMed ID: 9882707
[TBL] [Abstract][Full Text] [Related]
39. Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
Ragsdale DS; McPhee JC; Scheuer T; Catterall WA
Science; 1994 Sep; 265(5179):1724-8. PubMed ID: 8085162
[TBL] [Abstract][Full Text] [Related]
40. Irreversible block of human heart (hH1) sodium channels by the plant alkaloid lappaconitine.
Wright SN
Mol Pharmacol; 2001 Feb; 59(2):183-92. PubMed ID: 11160852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
